Literature DB >> 20433653

[Mycoserology--did we move on? Aspergillus].

R Kappe1, D Rimek.   

Abstract

Diseases caused by Aspergillus spp. are difficult to diagnose and thus require supplementary serological assays. This is the result of a selective review of the relevant literature with special regard to recent guidelines. In addition to conventional diagnostic tools (radiology, microscopy, culture) the measurement of the following serological markers is recommended, depending on the clinical type of aspergillosis: Invasive and chronic necrotising aspergillosis: Aspergillus-galactomannan antigen. Test format: EIA using the rat MAb EB-A2. Cut-off 0.5 (index). Monitoring of high risk patients: Twice weekly. Aspergillus-IgG (test format EIA) as confirmatory assay after recovery of the leukocyte function under therapy. Aspergilloma: Aspergillus IgG. Test format: EIA. Allergical aspergillosis: Aspergillus IgE. Test format: RAST. Galactomannan antigen detection rates high in the diagnosis of invasive aspergillosis. The evaluation of Aspergillus nucleic acid amplification assays is pending.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20433653     DOI: 10.1111/j.1439-0507.2009.01839.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  2 in total

1.  Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction.

Authors:  Rodrigo Lopes da Silva; Patrícia Ribeiro; Natacha Abreu; Teresa Ferreira; Teresa Fernandes; Alexandra Monteiro; Fátima Costa; Joana Caldas; Madalena Silva; Luísa Carande; Gilda Ferreira; António Conduto; Ernesto Cruz; Maria Henrique Sousa; António Silva Rodrigues; Isabel Costa; Joana Veiga; Aida Botelho de Sousa
Journal:  Clin Med Insights Oncol       Date:  2010-07-27

Review 2.  Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome.

Authors:  Richard C Barton
Journal:  Scientifica (Cairo)       Date:  2013-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.